Two hundred patients suffering from vaginal Trichomonas vaginalis infection were admitted to a double-blind clinical study. All patients provided a detailed history of previous episodes of vaginitis. All women were treated with one dose of nimorazole 2 g stat. In addition, one group of patients were vaccinated with SolcoTrichovac and the other group received a placebo ‘vaccination’. The immediate effect of the nimorazole treatment was comparable in both groups, relapses and reinfections, however, differed significantly after 4 weeks (p < 0.01) in favour of the SolcoTrichovac group. After 4 and 8 months, the effect of the vaccine in preventing reinfections was even more pronounced, with a statistical difference of p < 0.001 between the two groups of patients.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.